Vital Therapies Announces Second Quarter 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/26/2026
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Stock action shows confidence in central banks: BofA’s Hartnett
- Oil prices slide about 2% as US, Iran explore path out of war
- Why stocks held up despite rising yields and $100 oil? These 2 words explain it
- Barclays asks if equity markets are nearing the boiling point
- White House blocks CNN from Air Force One trip, Washington Post reports
- Exclusive-SK Hynix's Solidigm weighs IPO that could value the unit at up to $150 billion, sources say
- Merck and Daiichi Sankyo withdraw lung cancer drug application
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Fox Factory sells Marucci Sports for $225M, cuts debt
Vital Therapies (VTL) Tops Q2 EPS by 3c
August 7, 2018 4:12 PM EDTVital Therapies (NASDAQ: VTL) reported Q2 EPS of ($0.30), $0.03 better than the analyst estimate of ($0.33).
This is an exciting time for the Company. We are diligently working toward database lock for VTL-308 and expect to report topline results in the second half of... More
